On 25 October 2017
Glaxosmithkline Pharma will hold a meeting of the Board of Directors of the Company on 25 October 2017, to approve the Un-Audited Financial Results for the quarter and half year ended 30th September,2017Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
